S

SpyGlass Pharma Inc
D

SGP

28.890
USD
-0.03
(-0.10%)
مغلق
حجم التداول
3,749
الربح لكل سهم
-3
العائد الربحي
-
P/E
-17
حجم السوق
966,312,113
المقالات
المزيد

العنوان: SpyGlass Pharma Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company isdeveloping two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.